Niki BioSolutions, Inc. Operating Costs and Expenses
Niki BioSolutions, Inc. (NIKI) reported Operating Costs and Expenses of $1.82 million for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingCostsAndExpenses · last filed 2026-05-11
- Niki BioSolutions, Inc. operating costs and expenses for the quarter ending 2025-12-31 was $825.13K, a 117.34% increase year-over-year.
- Niki BioSolutions, Inc. operating costs and expenses for the quarter ending 2025-09-30 was $589.63K, a 14.84% decline year-over-year.
- Niki BioSolutions, Inc. operating costs and expenses for the quarter ending 2024-12-31 was $379.64K.
- Niki BioSolutions, Inc. operating costs and expenses for the quarter ending 2024-09-30 was $692.39K.
| Period end | Operating Costs and Expenses 3 month | Operating Costs and Expenses 6 month | Operating Costs and Expenses 9 month | Operating Costs and Expenses 12 month |
|---|---|---|---|---|
| 2025-12-31 | $825.13K derived: S-4/A 12 month − 6-K 9 month · filed 2026-05-11 | $1.41M derived: sum of 2 quarters · filed 2026-05-11 | $1.82M S-4/A · filed 2026-05-11 | |
| 2025-09-30 | $589.63K derived: 6-K 9 month − 6-K 6 month · filed 2026-01-22 | $992.40K 6-K · filed 2026-01-22 | ||
| 2025-06-30 | $402.77K 6-K · filed 2025-10-08 | |||
| 2024-12-31 | $379.64K derived: S-4/A 12 month − 6-K 9 month · filed 2026-05-11 | $1.07M derived: sum of 2 quarters · filed 2026-05-11 | $3.94M S-4/A · filed 2026-05-11 | |
| 2024-09-30 | $692.39K derived: 6-K 9 month − 6-K 6 month · filed 2026-01-22 | $3.56M 6-K · filed 2026-01-22 | ||
| 2024-06-30 | $2.87M 6-K · filed 2025-10-08 | |||
| 2023-12-31 | $11.16M S-4/A · filed 2026-05-11 | |||
| 2023-06-30 | $28.13K 6-K · filed 2023-12-22 | |||
| 2022-12-31 | $18.81M 6-K · filed 2025-10-08 |